Jump to content
Sclero Forums
Sign in to follow this  
Guest Sherrill

Clinical Risk Assessment Of Organ Manifestations In Systemic Sclerosis

Recommended Posts

Guest Sherrill

Clinical risk assessment of organ manifestations in systemic sclerosis - a report from the EULAR Scleroderma Trials And Research (EUSTAR) group data base. Diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subsets are associated with particular organ manifestations, but in this analysis the clinical distinction appeared superseded by an antibody based classification in predicting some scleroderma complications. PubMed. Ann rheumatologist Dis. 2007 Feb 1. (Also see: Types of Scleroderma and Antibodies)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information. http://www.sclero.org/news/a-to-z.html

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×